Sath Shukla's Net Worth
$1.86 Million
Who is Sath Shukla?
Sath Shukla has an estimated net worth of $1.86 Million. This is based on reported shares across multiple companies, which include ZIOPHARM ONCOLOGY INC, and Spero Therapeutics, Inc..
SEC CIK
Sath Shukla's CIK is 0001782817
Past Insider Trading and Trends
2020 was Sath Shukla's most active year for acquiring shares with 2 total transactions. Sath Shukla's most active month to acquire stocks was the month of January. 2023 was Sath Shukla's most active year for disposing of shares, totalling 3 transactions. Sath Shukla's most active month to dispose stocks was the month of July. 2024 saw Sath Shukla paying a total of $0.00 for 679,501 shares, this is the most they've acquired in one year. In 2024 Sath Shukla cashed out on 78,751 shares for a total of $111,441.17, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ZIOPHARM ONCOLOGY INC (TCRT) Snapshot price: $2.83
EVP, Chief Financial OfficerSath Shukla owns 80,500 units of Common Stock which is worth $227,815.00.acquired a total of 80,500 shares in ZIOPHARM ONCOLOGY INC.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 80.5K |
—
|
—
| 80.5K |
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Spero Therapeutics, Inc. (SPRO) Snapshot price: $1.3101
CEO & PresidentSath Shukla owns 1,140,809 units of Common Stock which is worth $1,494,573.87. From 2021 to 2024 Sath Shukla acquired a total of 1,273,539 shares in Spero Therapeutics, Inc., Sath also disposed a total of 100,289 shares of Spero Therapeutics, Inc. equalling to $141,939.46.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.24% | -2.76K |
$1.35 | -$3,721.95 | 1.14M |
Aug 27
| |||
Form 4
| +105.42% | 603.51K |
$1.42 | -$107,719.22 | 1.18M |
Feb 1 - Feb 5
| |||
Form 4
| -1.04% | -6.02K |
$1.29 | -$7,747.94 | 572.5K |
Aug 28 - Aug 29
| |||
Form 4
| +85.12% | 266K |
—
|
—
| 578.52K |
Aug 1
| |||
Form 4
| +457.43% | 256.45K |
$1.83 | -$17,372.36 | 312.52K |
Scheduled
|
Feb 1 - Feb 2
| ||
Form 4
| -9.69% | -6.02K |
$0.89 | -$5,377.99 | 56.06K |
Scheduled
|
Aug 29
| ||
Form 4
| +157.95% | 38.01K |
—
|
—
| 62.08K |
Feb 1
| |||
Form 4
|
∞
| 24.07K |
—
|
—
| 24.07K |
Aug 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||